title: Candida parapsilosis produces prostaglandins from exogenous arachidonic acid and OLE2 is not required for their synthesis.
abstract: Prostaglandins are C20 fatty acid metabolites with diverse biological functions. In mammalian cells, prostaglandins are produced from arachidonic acid (AA) via cyclooxygenases (COX1 and COX2). Although fungi do not possess cyclooxygenase homologues, several pathogenic species are able to produce prostaglandins from host-derived arachidonic acid. In this study, we characterized the prostaglandin profile of the emerging human pathogen Candida parapsilosis with HPLC-MS and compared it to that of C. albicans. We found that both species synthesized prostaglandins (mainly PGD2 and PGE2) from exogenous AA. Furthermore, as OLE2 has been associated with prostaglandin synthesis in C. albicans, we generated homozygous OLE2 deletion mutants in C. parapsilosis and examined their PGE2 production. However, the PGE2 production of the OLE2 KO strain was similar to that of wild type (WT), indicating that OLE2 is not required for prostaglandin synthesis in C. parapsilosis. Interestingly, analyses of the fatty acid composition of WT and OLE2 KO cells by gas chromatography (GC) highlighted the accumulation of palmitoleic and oleic acid in the OLE2 deletion mutant. The OLE2 KO cells were killed more efficiently by human monocytes-derived macrophages (MDMs) as well as induced higher interleukin-10 (IL-10) secretion, indicating that OLE2 affects the virulence of C. parapsilosis. Taken together, these results contribute to the better understanding of fatty acid biosynthesis pathways in C. parapsilosis.
authors: a Department of Microbiology ; University of Szeged ; Szeged , Hungary.
authors: Zsuzsanna
authors: Z
authors: Grózer
authors: Adél
authors: A
authors: Tóth
authors: Renáta
authors: R
authors: Tóth
authors: Anita
authors: A
authors: Kecskeméti
authors: Csaba
authors: C
authors: Vágvölgyi
authors: Joshua D
authors: JD
authors: Nosanchuk
authors: András
authors: A
authors: Szekeres
authors: Attila
authors: A
authors: Gácser
mesh_terms: D016718:Arachidonic Acid / Q000378:metabolism; D002175:Candida / Q000235:genetics* / Q000378:metabolism*; D005229:Fatty Acids, Monounsaturated / Q000378:metabolism; D005656:Fungal Proteins / Q000235:genetics*; D006801:Humans; D016753:Interleukin-10 / Q000378:metabolism; D008264:Macrophages / Q000276:immunology; D019301:Oleic Acid / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis*; D013230:Stearoyl-CoA Desaturase / Q000235:genetics*
chemical_list: D005229:Fatty Acids, Monounsaturated; D005656:Fungal Proteins; C508609:IL10 protein, human; D011453:Prostaglandins; D016753:Interleukin-10; C008757:palmitoleic acid; D016718:Arachidonic Acid; D019301:Oleic Acid; D013230:Stearoyl-CoA Desaturase
keywords: Candida parapsilosis; fatty acid composition; immunomodilation; prostaglandins
references: J Bacteriol. 2000 Jul;182(13):3655-60
references: 10850979
references: Infect Immun. 2001 May;69(5):2957-63
references: 11292712
references: Science. 2001 Nov 30;294(5548):1871-5
references: 11729303
references: Infect Immun. 2002 Jan;70(1):400-2
references: 11748207
references: Trends Immunol. 2002 Mar;23(3):144-50
references: 11864843
references: Prog Lipid Res. 2004 Jan;43(1):3-35
references: 14636669
references: Microbiology. 2004 Jun;150(Pt 6):1991-2003
references: 15184585
references: Microbiol Mol Biol Rev. 2004 Sep;68(3):501-17, table of contents
references: 15353567
references: Gene. 2004 Oct 27;341:119-27
references: 15474295
references: Infect Immun. 2004 Nov;72(11):6206-10
references: 15501745
references: J Leukoc Biol. 1995 Sep;58(3):351-8
references: 7665991
references: Mol Cell Biol. 1999 May;19(5):3415-22
references: 10207065
references: Biochim Biophys Acta. 2007 Mar;1771(3):271-85
references: 16920014
references: Biochim Biophys Acta. 2007 Mar;1771(3):255-70
references: 16950653
references: Infect Immun. 2007 Jul;75(7):3498-505
references: 17470538
references: J Clin Invest. 2007 Oct;117(10):3049-58
references: 17853941
references: FEMS Immunol Med Microbiol. 2008 Oct;54(1):122-8
references: 18647352
references: Clin Microbiol Rev. 2008 Oct;21(4):606-25
references: 18854483
references: J Biol Chem. 2009 Jul 17;284(29):19754-64
references: 19487691
references: Crit Rev Microbiol. 2009;35(4):283-309
references: 19821642
references: J Appl Genet. 2010;51(2):225-32
references: 20453313
references: Int J Infect Dis. 2013 Aug;17(8):e621-3
references: 23535300
references: Virulence. 2014 May 15;5(4):555-62
references: 24626151
references: PLoS One. 2009;4(12):e8421
references: 20027295
references: FEBS Lett. 2009 Dec 17;583(24):3905-13
references: 19854183
references: Infect Immun. 2011 Jan;79(1):136-45
references: 20974817
references: Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22044-9
references: 21135205
references: Virulence. 2011 Nov-Dec;2(6):538-41
references: 22030857
references: Appl Microbiol Biotechnol. 2012 Jul;95(1):1-12
references: 22562166
references: Mediators Inflamm. 2012;2012:503128
references: 22791937
references: Lipids Health Dis. 2012;11:100
references: 22873782
references: PLoS One. 2013;8(3):e59373
references: 23527176
references: Antimicrob Agents Chemother. 2007 Oct;51(10):3537-45
references: 17698629